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A B S T R A C T
Background
Uncertainty exists regarding the management of newborn infants with a bloodstream infection and a central venous catheter in place.
The central venous catheter may act as a nidus for infecting organisms and observational studies have suggested that early removal of
the catheter is associated with a lower incidence of persistent or complicated infection. However, since central venous catheters provide
secure vascular access to deliver nutrition and medications, the possible harms of early removal versus expectant management also need
to be considered.
Objectives
To determine the effect of early removal versus expectant management of central venous catheters on morbidity and mortality in
newborn infants with bloodstream infections.
Search methods
We used the standard search strategy of the Cochrane Neonatal Review Group. This included searches of the Cochrane Central Register
of Controlled Trials (CENTRAL 2015, Issue 11), MEDLINE (1966 to October 2015), EMBASE (1980 to October 2015), CINAHL
(1982 to October 2015), conference proceedings and previous reviews.
Selection criteria
Randomised and quasi-randomised controlled trials that compared early removal versus expectant management of central venous
catheters in neonates with bloodstream infections.
Data collection and analysis
We used the standard methods of the Cochrane Neonatal Review Group.
Main results
We did not identify any eligible randomised controlled trials.
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Authors’ conclusions
There are no trial data to guide practice regarding early removal versus expectant management of central venous catheters in newborn
infants with bloodstream infections. A simple and pragmatic randomised controlled trial is needed to resolve the uncertainty about
optimal management in this common and important clinical scenario.
P L A I N L A N G U A G E S U M M A R Y
Early removal versus expectant management of central venous catheters in newborn infants with bloodstream infection
Review question: In newborn infants with a bloodstream infection who have a central venous catheter in place, does early removal of
the catheter reduce the risk of complications, including death and long-term disability?
Background: Infection in the bloodstream is a frequent and harmful complication for newborn infants who have a central venous
catheter (a cannula that extends several centimetres into the infant’s blood vessels). Bloodstream infection may cause death and disability.
When infants develop a bloodstream infection, clinicians need to decide whether or not to remove the catheter. While the catheter
may provide a secure route for delivering drugs and nutrition, it may also be a place for infecting organisms to grow and cause long-
term or more severe infection.
Study characteristics/key results: We did not ﬁnd any randomised controlled trials that addressed this question.
Conclusions: There are no trial data available to help clinicians to address this common clinical dilemma. Due to the potential for
beneﬁt and harm, such a trial is warranted.
B A C K G R O U N D
Description of the condition
Bloodstream infection is the most common serious complication
associated with the use of central venous catheters (CVCs) includ-
ing peripherally inserted percutaneous CVCs, umbilical catheters
and subcutaneously tunnelled CVCs in newborn infants. Between
5% to 30% of neonates with a CVC in situ develop a bloodstream
infection (Mahieu 2001; Cartwright 2004; van der Zwet 2005;
Garland 2008; Hoang 2008; Ohki 2008; Olsen 2009; O’Grady
2011). The reported incidence varies with the case deﬁnition and
with the demographic characteristics of the populations studied.
The incidence of bloodstream infection is higher in very preterm
and very low birth weight (VLBW) infants, reﬂecting their level
and duration of exposure to invasive procedures and intensive care
(Makhoul 2002; Stoll 2002; Stoll 2003; Shane 2013). Nosocomial
(acquired in hospital) bloodstream infection is more strongly as-
sociated with the use of peripherally inserted percutaneous CVCs
and subcutaneously tunnelled catheters than with the use of um-
bilical catheters even after accounting for infant characteristics
and illness severity (Chien 2002). However, it is not certain to
what extent CVC use is an independent risk factor for a blood-
stream infection or whether an association exists because infants
who are smaller, less mature, sicker and receiving more intensive
and invasive support are also more likely to have a CVC in situ.
A Cochrane review of randomised controlled trials of peripherally
inserted percutaneous CVCs versus peripheral cannulae for deliv-
ering parenteral nutrition to neonates did not ﬁnd any evidence
of an effect on invasive infection rates (Ainsworth 2007).
Coagulase-negative staphylococci cause about half of all CVC-
related bloodstream infections in neonates (Isaacs 2003). Other
pathogens include Gram-negative bacilli (mainly enteric bacilli),
Gram-positive cocci (Staphylococcus aureus, enterococci) and fungi
(predominantlyCandida species) (Stoll 2002; Isaacs 2004;Gordon
2006). Neonates, particularly VLBW infants, with bloodstream
infections have a higher risk of mortality and a range of impor-
tant morbidities, including the need for intensive care and me-
chanical ventilation, bronchopulmonary dysplasia, necrotising en-
terocolitis, retinopathy of prematurity and prolonged hospitalisa-
tion (Stoll 2002; Chapman 2003; Adams-Chapman 2006; Bassler
2009). These higher rates of mortality and serious morbidity are
usually associated with Gram-negative enteric bacillus or fungal
infection. Coagulase-negative staphylococcal infection, although
common, is associated with a more benign clinical course. Menin-
gitis and other deep-seated involvement is rare and attributable
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mortality is much lower than with infection from other organ-
isms.However, even ’low-grade’ coagulase-negative staphylococcal
bloodstream infections may generate inﬂammatory cascades asso-
ciated with both acute morbidity (e.g. metabolic, respiratory or
thermal instability, thrombocytopenia) and long-term white mat-
ter and other brain damage that may result in neurodevelopmental
disability (Stoll 2004; Khashu 2006).
Description of the intervention
Aclinicalmanagement dilemma existswhen aneonatewith aCVC
in situ develops signs consistent with a bloodstream infection.
There is substantial uncertainty among clinicians about whether
early CVC removal versus retention and expectant management
is the better option (Karlowicz 2002; Rubin 2002). The CVC
provides secure vascular access that allows continued provision of
ﬂuids, nutrition and medications, including anti-infective agents.
If the CVC is removed then an alternative route for drug and ﬂuid
administration, either a peripheral cannula or a new CVC, may be
required. However, the CVC, or an associated thrombus, may act
as a harbour for micro-organisms thus decreasing the effectiveness
of anti-infective agents and perpetuating the invasive infection,
inﬂammatory cascades and end-organ damage (Thornburg 2008).
The decision whether to retain or to remove the CVC depends on
the perceived balance between these potential beneﬁts and risks
and may be affected by additional factors including the infant’s
clinical status, the level of need for continued vascular access and
the ease with which replacement vascular access can be secured.
Surveys of practice suggest that clinicians generally elect to retain
an existing CVCin situ in neonates with ’suspected’ bloodstream
infection; that is, a possible infection treated empirically with an-
tibiotics but not yet conﬁrmed by microbiological culture from
blood (Benjamin 2001; Rubin 2002). Furthermore, many clini-
cians opt for expectant CVC management in neonates and young
infants with a conﬁrmed bloodstream infection due to coagulase-
negative staphylococci. However, some clinicians elect to remove
the CVC at an early stage whenever infection is suspected because
the early clinical features of a bloodstream infection due to Gram-
negative bacilli or fungi can be similar to those due to a coagulase-
negative staphylococcal infection (Benjamin 2000).
Several additional factors need to be considered when deciding
whether to remove or retain a CVC in neonates with bloodstream
infections. Clinical signs of bloodstream infections in neonates,
especially very preterm and VLBW infants, are generally non-spe-
ciﬁc. Similarly, laboratory measures (biomarkers) have low predic-
tive value for bloodstream infections (Fowlie 1998; Malik 2003).
Most neonates who have a suspected bloodstream infection and
who undergo ’sepsis evaluation’ do not have the infection con-
ﬁrmed subsequently (Buttery 2002). Since clinical signs and labo-
ratory markers are generally unreliable predictors of a true blood-
stream infection, a policy of early CVC removal when the infection
is suspected would inevitably result in many unnecessary interven-
tions. Even in situations where an infection has been conﬁrmed
by microbiological culture from blood this may represent con-
tamination from skin commensals, particularly coagulase-negative
staphylococci (Isaacs 2003). Conversely, culture of blood samples
that are of insufﬁcient volume may give falsely reassuring negative
results (Jawaheer 1997; Connell 2007).
How the intervention might work
Early removal of a CVC in neonates with nosocomial bloodstream
infections may hasten microbiological clearance and thereby re-
duce the incidence of end-organ involvement and damage in-
cluding that due to inﬂammatory cascades (Chapman 2003).
Observational studies have provided some evidence that prompt
CVC removal following a conﬁrmed bloodstream infection due to
Staphylococcus aureus, enterococci, Gram-negative bacilli or Can-
dida species reduces the likelihood of persistent or complicated
bacteraemia or fungaemia with end-organ involvement (Eppes
1989; Karlowicz 2000; Benjamin 2001; Nazemi 2003). Data from
retrospective cohort studies also suggest that early CVC removal
in neonates with a conﬁrmed coagulase-negative staphylococcal
infection is associated with a reduced risk of persistent bacteraemia
and end-organ involvement and that infants with persistent coag-
ulase-negative staphylococcal bacteraemia only achieve microbio-
logical cure when theCVC is removed (Benjamin 2001; Karlowicz
2002).However, these observational studies need to be interpreted
cautiously since their ﬁndings may be due to confounding factors
such as clinicians electing to delay CVC removal in smaller, less
mature or sicker infants.
Why it is important to do this review
Uncertainty exists about the balance between the putative beneﬁts
and harms associated with early removal versus expectant man-
agement of CVC in neonates with bloodstream infections. This
intervention has the potential to affect several major outcomes
for this population. Observational data may be subject to various
biases that limit validity and utility to inform practice, therefore
an attempt to detect, appraise and synthesise evidence from ran-
domised controlled trials is needed.
Related Cochrane reviews
Other Cochrane reviews assess the effects of strategies to prevent
CVC-related infection in newborn infants including antimicrobial
impregnation or antibiotic locks (Balain 2015; Taylor 2015). Two
other reviews will evaluate the evidence for short- versus longer-
term CVC use for newborn infants (Gordon 2016a; Gordon
2016b).
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O B J E C T I V E S
To determine the effect of early removal versus expectant manage-
ment of central venous catheters on morbidity and mortality in
newborn infants with bloodstream infections.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised or quasi-randomised controlled trials including clus-
ter-randomised trials.
Types of participants
Newborn infants (including preterm infants up to 44 weeks post-
menstrual age) with suspected or conﬁrmed bloodstream infec-
tions who have a CVC in situ.
• ’Suspected’ bloodstream infection: any clinical or laboratory
(or both) criteria that trigger clinicians to undertake a ’sepsis’
evaluation that includes a blood culture.
• ’Conﬁrmed’ bloodstream infection: determined by
microbiological culture from blood. Blood samples may have
been obtained from peripheral sites or from an indwelling CVC.
Types of interventions
• Interventions: removal of CVC within 24 hours of (i)
evaluation of a suspected infection or (ii) microbiological
conﬁrmation of a bloodstream infection. Options for
maintaining nutrient and drug delivery may have included some
or all of: replacement CVC, peripheral (short) catheter,
subcutaneous infusion (for ﬂuids), intramuscular injection (for
medications), enteral administration.
• Control: expectant management; intended retention of
CVC during (i) evaluation and treatment of a suspected
bloodstream infection or (ii) at least 24 hours after
microbiological conﬁrmation of a bloodstream infection.
Indications for later selective catheter removal may be
determined by primary investigators.
Since infants may experience more than one episode of a blood-
stream infection, eligible trials should have enrolled participants
on one occasion only, with management of subsequent infections
determined by clinician preference.
Types of outcome measures
Primary outcomes
• Mortality from study entry (due to all causes):
◦ before 28 days after birth;
◦ up to 44 weeks postmenstrual age; until one year
corrected for preterm gestation;
◦ at latest follow-up assessment.
• Neurodevelopmental outcomes assessed after 12 months
postmenstrual age using validated tools: neurological evaluations,
developmental scores and classiﬁcations of disability, including
auditory and visual disability. We will deﬁne neurodevelopmental
impairment as the presence of one or more of the following: non-
ambulant cerebral palsy, developmental delay (developmental
quotient > two standard deviations below population mean),
blindness (visual acuity less than 6/60) or deafness (any hearing
impairment requiring or unimproved by ampliﬁcation).
Secondary outcomes
• Persistent or recurrent infection; proportion of neonates
with:
◦ positive blood cultures > 48 hours after starting
antimicrobial therapy;
◦ positive blood cultures < one week after stopping
antimicrobial therapy;
◦ deep-seated infection (meningitis, osteomyelitis,
endocarditis, peritonitis) diagnosed > 48 hours after starting
antimicrobial therapy and < one week after stopping
antimicrobial therapy.
• Other morbidity developing after enrolment in trial:
◦ receipt of mechanical ventilation;
◦ duration of mechanical ventilation (days);
◦ receipt of inotrope support;
◦ receipt of blood product transfusion (erythrocytes,
platelets, coagulation factors) reported either as a dichotomous
(any transfusion or none) or continuous outcome (number of
transfusions the infants received) as deﬁned by primary
investigators;
◦ incidence of bronchopulmonary dysplasia (oxygen
supplementation at 36 weeks postmenstrual age);
◦ incidence of necrotising enterocolitis (Bell stage 2 or
3);
◦ incidence of retinopathy of prematurity: a) any stage;
b) requiring treatment;
◦ duration of intensive care unit or hospital admission
(days).
• Parenteral nutrient input from trial enrolment until
establishment of full enteral feeding:
◦ average daily input of calories (kcal/kg/day) and
protein (g/kg/day);
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◦ average daily proportion of prescribed calories and
protein that were actually delivered.
• Number of cannulae/catheters per infant during trial
period.
• Growth from trial enrolment until establishment of full
enteral feeding:
◦ weight gain (g/day or g/kg/day);
◦ linear growth (mm/week);
◦ head growth (mm/week);
◦ skinfold thickness growth (mm/week).
Search methods for identification of studies
We used the standard search strategy of the Cochrane Neonatal
Review Group.
Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL 2015, Issue 11), MEDLINE (1966 to October
2015), EMBASE (1980 to October 2015) and CINAHL (1982
to October 2015) using a combination of the following text words
and MeSH terms:
[Infant, Newborn OR Infant, Premature OR Infant, Low Birth
Weight OR infan* OR neonat*] AND [Catheters, Indwelling/
adverse effects OR Catheterization, Central Venous OR central
near3 cathet*OR central near3 cannul* OR central near3 line OR
CVC OR CVL OR PCVC OR PICC OR Umbilical, Veins OR
UVC OR UAC OR umbilical near3 cathet* OR umbilical near3
cannul* OR umbilical near3 line OR Broviac OR Hickman].
We limited the search outputs with the relevant search ﬁlters for
clinical trials as recommended in the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). We did not apply
any language restrictions.
We searched ClinicalTrials.gov and Current Controlled Trials for
completed or ongoing trials.
Searching other resources
We examined the references in studies identiﬁed as potentially
relevant.
We examined reference lists in previous reviews and included stud-
ies. We searched the proceedings of the annual meetings of the
Pediatric Academic Societies (1993 to 2015), the European Soci-
ety for Pediatric Research (1995 to 2015), the Royal College of
Paediatrics and Child Health (2000 to 2015), the Perinatal Soci-
ety of Australia and New Zealand (2000 to 2015), the European
Society for Paediatric Infectious Diseases (2005 to 2015) and the
Infectious Diseases Society of America (2003 to 2014). Trials re-
ported only as abstracts were eligible if sufﬁcient information was
available from the report, or from contact with the authors, to
fulﬁl the inclusion criteria.
Data collection and analysis
Weplanned touse the standardmethods of theCochraneNeonatal
Review Group.
Selection of studies
Two authors planned to screen independently the title and abstract
of all studies identiﬁed by the above search strategy and assess
the full articles for all potentially relevant trials. We planned to
exclude any studies that did not meet all of the inclusion criteria
and to state the reason for exclusion. We intended to discuss any
disagreements until we reached a consensus.
Data extraction and management
If we had identiﬁed any eligible studies, we planned to use a
data collection form to aid extraction of information on design,
methodology, participants, interventions, outcomes and treatment
effects from each included study. We intended to discuss any dis-
agreements until we reached a consensus. If data from the trial
reports were insufﬁcient, we planned to contact the trialists for
further information.
Assessment of risk of bias in included studies
We planned to use the criteria and standard methods of the
Cochrane Neonatal Group to assess the methodological quality of
any included trials. Two authors should conduct the assessment of
risk of bias and resolve disagreements in consultation with a third
author. We planned to request additional information from the
trial authors to clarify methodology and results if necessary.
We planned to evaluate the following issues in the ’Risk of bias’
tables:
Random sequence generation - the method used to generate the
allocation sequence:
• low risk - any truly random process, e.g. random number
table; computer random number generator;
• high risk - any non-random process, e.g. odd or even date
of birth; hospital or clinic record number; and
• unclear risk - no or unclear information provided.
Allocation concealment - the method used to conceal the alloca-
tion sequence:
• low risk - e.g. telephone or central randomisation;
consecutively numbered, sealed, opaque envelopes;
• high risk - open random allocation, e.g. unsealed or non-
opaque envelopes, alternation; date of birth; and
• unclear - no or unclear information provided.
Blinding - the methods used to blind participants, clinicians and
caregivers, and outcome assessors for different outcomes:
• low risk;
• high risk; and
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• unclear.
Incomplete outcome data - the completeness of data, including
attrition and exclusions from the analysis, for each outcome and
any reasons for attrition or exclusion, where reported:
• low risk: < 10% missing data;
• high risk: > 10% missing data; and
• unclear risk: no or unclear information provided.
Measures of treatment effect
We planned to calculate risk ratio (RR) and risk difference (RD)
for dichotomous data and mean difference (MD) for continuous
data, with respective 95% conﬁdence intervals (CI). We planned
to determine the number needed to treat to beneﬁt (NNTB) or to
harm (NNTH) for a statistically signiﬁcant reduction in the RD.
Unit of analysis issues
We planned that the unit of analysis would be the participating
infant in individually randomised trials and the neonatal unit (or
sub-unit) for cluster-randomised trials.
More than one episode of a bloodstream infection can occur in the
same infant with a CVC. We planned to include only one episode
per infant to avoid a unit of analysis problem.
Assessment of heterogeneity
We planned to examine the treatment effects of individual trials
and heterogeneity between trial results by inspecting the forest
plots. We planned to calculate the I² statistic for each analysis to
quantify inconsistency across studies and to describe the percent-
age of variability in effect estimates that may be due to hetero-
geneity rather than sampling error.
Assessment of reporting biases
If there were data from more than 10 trials included in a meta-
analysis, we intended to conduct a funnel plot analysis.
Data synthesis
Weplanned toperformmeta-analyses using the ﬁxed-effectmodel.
Quality of evidence
Two authors planned to assess independently the quality of the
evidence found for outcomes identiﬁed as critical or important for
clinical decision-making (mortality) using the Grading of Recom-
mendations Assessment, Development and Evaluation (GRADE)
approach (Guyatt 2011a). The GRADE approach results in an as-
sessment of the quality of a body of evidence as one of four grades
(Schünemann 2013):
• High: We are very conﬁdent that the true effect lies close to
that of the estimate of the effect.
• Moderate: We are moderately conﬁdent in the effect
estimate: the true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
• Low: Our conﬁdence in the effect estimate is limited: the
true effect may be substantially different from the estimate of the
effect.
• Very low: We have very little conﬁdence in the effect
estimate: the true effect is likely to be substantially different from
the estimate of effect.
We planned to consider evidence from randomised controlled tri-
als as high quality, but they could be downgraded based on con-
sideration of any of ﬁve areas:
• design and risk of bias (Guyatt 2011b);
• consistency across studies (Guyatt 2011c);
• precision of estimates (Guyatt 2011d);
• directness of the evidence (Guyatt 2011e);
• presence of publication bias.
In cases where we considered the risk of bias arising from inad-
equate concealment of allocation, randomised assignment, com-
plete follow-up or blinded outcome assessment to reduce our con-
ﬁdence in the effect estimates, we planned to downgrade the qual-
ity of evidence accordingly (Guyatt 2011b). We planned to evalu-
ate consistency by examining similarity of point estimates, extent
of overlap of conﬁdence intervals and by using statistical tests of
heterogeneity (I²). The quality of evidence would be downgraded
when large and unexplained inconsistency across studies results
was present (i.e. some studies suggest important beneﬁt and others
no effect or harm without a clinical explanation) (Guyatt 2011c).
We planned to assess precision according to the 95% conﬁdence
interval (CI) around the pooled estimate of effect (Guyatt 2011d).
When trials were conducted in populations other than the target
population, we planned to downgrade the quality of evidence be-
cause of indirectness (Guyatt 2011e).
We planned to enter the data (pooled estimates of the effects and
corresponding 95% CI) and make explicit judgements for each of
the above aspects in theGuidelineDevelopmentTool, the software
used to create Summary of Findings (SoF) tables (GRADEpro
2008). We planned to explain judgements involving the assess-
ment of the study characteristics in footnotes or comments in the
SoF table.
Subgroup analysis and investigation of heterogeneity
We pre-speciﬁed separate comparisons for infants with:
• suspected infection;
• conﬁrmed infection.
For conﬁrmed infection, we planned to perform subgroup analyses
by infecting organism:
• coagulase-negative staphylococci;
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• other Gram-positive cocci;
• Gram-negative bacillus;
• fungi.
If sufﬁcient data were available, we would have performed further
subgroup analyses by:
• birth weight and gestational age: VLBW infants (< 1500 g)
and very preterm infants (< 32 weeks gestation at birth);
• CVC type: peripherally inserted percutaneous CVCs;
subcutaneously tunnelled catheters; umbilical catheters.
If substantial heterogeneity had been detected (I² > 50%), we
planned to explore the possible causes (for example, differences
in study design, participants, interventions or completeness of
outcome assessments) in sensitivity analyses.
R E S U L T S
Description of studies
We did not identify any studies or ongoing trials that met our
inclusion criteria.
Results of the search
We did not identify any eligible trials.
Risk of bias in included studies
We did not identify any eligible trials.
Effects of interventions
We did not identify any eligible trials.
D I S C U S S I O N
Given that nosocomial bloodstream infection in neonates with a
central venous catheter (CVC) in place is a common and impor-
tant clinical problem and that substantial uncertainty and varia-
tion in practice exists with regard to early CVC removal versus ex-
pectant management, it is surprising that this question has not yet
been addressed in any randomised controlled trials. This may in
part be due to historical differences and inconsistencies in deﬁning
CVC-associated bloodstream infections. Over the past 20 years,
consensus deﬁnitions of nosocomial infections have become ac-
cepted more widely in practice, for example in neonatal network
benchmarking and audit process where infection incidence is an
established key quality indicator (Stoll 2002; Lee 2009). The avail-
ability of validated deﬁnitions should help in planning future trials
and facilitate synthesis of data from individual trials that adhere
to broadly consistent deﬁnitions (Modi 2009).
In the absence of trial data, decisions regarding the timing of re-
moval of CVCs in infants with bloodstream infections continue
to rely on the ﬁndings of observational studies. Some retrospective
cohort studies have indicated that bloodstream infections progress
to persistent bacteraemia or fungaemia with end-organ damage if
the CVC is not removed promptly (Eppes 1989; Karlowicz 2000;
Benjamin 2001; Nazemi 2003; Tsai 2012). However, these studies
have inherent methodological weaknesses with potential for bias
and should be interpreted with caution since their ﬁndings may
be due to confounding factors such as clinicians electing to delay
CVC removal in smaller, less mature or sicker infants. The varia-
tion in policy and practice between neonatal centres and clinicians
reﬂects the ongoing uncertainty with which the available observa-
tional data are viewed (Karlowicz 2002; Rubin 2002).
Similarly, there appear to be limited data to inform decisions
about CVC removal in other populations of patients with blood-
stream infections (Rijnders 2004; O’Grady 2011; Deliberato
2012; Lorente 2014). Practice guidelines published by the Euro-
pean Society for Clinical Nutrition and Metabolism and the In-
fectious Diseases Society of America recommend that peripherally
inserted percutaneous CVCs should be removed in patients with a
bloodstream infection. However, the level of evidence to support
these statements is acknowledged to be low, being based largely
on data from retrospective cohort studies (Mermel 2009; Pittiruti
2009).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There are no randomised controlled trials to inform practice. Ret-
rospective cohort studies suggest that early central venous catheter
(CVC) removal is associated with a lower risk of persistent in-
fection but these ﬁndings were not systematically reviewed and
should be interpreted with caution because of biases inherent in
the study design.
Implications for research
Given the potential for beneﬁt and harm to be associated with the
timing of removal of the CVC in a neonate with a bloodstream
infection, a pragmatic randomised controlled trial of early removal
versus expectant management seems warranted. Such a trial might
ﬁrst address this issue in infants with conﬁrmed bloodstream infec-
tions (deﬁned using established and validated criteria) and should
ideally be powered to allow pre-speciﬁed subgroup analyses based
on the infecting organism.
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